Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. uri icon

authors

  • Scafoglio, Claudio R
  • Elashoff, David
  • Walser, Tonya
  • Yanagawa, Jane
  • Aberle, Denise R
  • Barrio, Jorge R
  • Dubinett, Steven M
  • Shackelford, David B
  • Villegas, Brendon
  • Abdelhady, Gihad
  • Bailey, Sean T
  • Liu, Jie
  • Aditya S Shirali, MD, FACS
  • Wallace, W Dean
  • Magyar, Clara E
  • Grogan, Tristan R

publication date

  • November 14, 2018